Business Description
DBV Technologies SA
NAICS : 325412
SIC : 2834
Compare
Compare
Traded in other countries / regions
DBV.FranceDBV.Germany0QAJ.UKDBVT.USA IPO Date
2014-10-22Description
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node in order to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.87 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 37.1 | |||||
| 3-Year EPS without NRI Growth Rate | 34.6 | |||||
| 3-Year FCF Growth Rate | 43.1 | |||||
| 3-Year Book Growth Rate | -19.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.62 | |||||
| 9-Day RSI | 66.43 | |||||
| 14-Day RSI | 63.09 | |||||
| 6-1 Month Momentum % | -18.08 | |||||
| 12-1 Month Momentum % | -11.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.56 | |||||
| Quick Ratio | 7.56 | |||||
| Cash Ratio | 7.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -26 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -57.79 | |||||
| ROA % | -46.22 | |||||
| ROIC % | -233.01 | |||||
| ROC (Joel Greenblatt) % | -494.59 | |||||
| ROCE % | -53.86 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.54 | |||||
| Price-to-Tangible-Book | 1.54 | |||||
| EV-to-EBIT | -1.21 | |||||
| EV-to-Forward-EBIT | -1.4 | |||||
| EV-to-EBITDA | -1.5 | |||||
| EV-to-Forward-EBITDA | -1.46 | |||||
| EV-to-Forward-Revenue | 16.6 | |||||
| EV-to-FCF | -1.98 | |||||
| Price-to-Net-Current-Asset-Value | 1.75 | |||||
| Price-to-Net-Cash | 1.91 | |||||
| Earnings Yield (Greenblatt) % | -82.64 |
How DBV Technologies SA (DBVT) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:DBVT
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
DBV Technologies SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.64 | ||
| Beta | 0.91 | ||
| Volatility % | 87.42 | ||
| 14-Day RSI | 63.09 | ||
| 14-Day ATR ($) | 0.104045 | ||
| 20-Day SMA ($) | 1.586495 | ||
| 12-1 Month Momentum % | -11.04 | ||
| 52-Week Range ($) | 1.08 - 3.43 | ||
| Shares Outstanding (Mil) | 188.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DBV Technologies SA Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
DBV Technologies SA Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
DBV Technologies SA Frequently Asked Questions
What is DBV Technologies SA(DBVT)'s stock price today?
The current price of DBVT is $1.66. The 52 week high of DBVT is $3.43 and 52 week low is $1.08.
When is next earnings date of DBV Technologies SA(DBVT)?
The next earnings date of DBV Technologies SA(DBVT) is 2023-05-02 Est..
Does DBV Technologies SA(DBVT) pay dividends? If so, how much?
DBV Technologies SA(DBVT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
